JP2013516978A5 - - Google Patents

Download PDF

Info

Publication number
JP2013516978A5
JP2013516978A5 JP2012548518A JP2012548518A JP2013516978A5 JP 2013516978 A5 JP2013516978 A5 JP 2013516978A5 JP 2012548518 A JP2012548518 A JP 2012548518A JP 2012548518 A JP2012548518 A JP 2012548518A JP 2013516978 A5 JP2013516978 A5 JP 2013516978A5
Authority
JP
Japan
Prior art keywords
adenovirus
seq
preproendothelin promoter
mouse preproendothelin
transgene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012548518A
Other languages
English (en)
Japanese (ja)
Other versions
JP6009357B2 (ja
JP2013516978A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2011/050137 external-priority patent/WO2011086509A1/en
Publication of JP2013516978A publication Critical patent/JP2013516978A/ja
Publication of JP2013516978A5 publication Critical patent/JP2013516978A5/ja
Application granted granted Critical
Publication of JP6009357B2 publication Critical patent/JP6009357B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012548518A 2010-01-12 2011-01-12 アデノウイルスベクターの生産方法およびそれによって生成されるウイルス調製物 Expired - Fee Related JP6009357B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US29415810P 2010-01-12 2010-01-12
US61/294,158 2010-01-12
PCT/IB2011/050137 WO2011086509A1 (en) 2010-01-12 2011-01-12 Methods of producing adenovirus vectors and viral preparations generated thereby

Publications (3)

Publication Number Publication Date
JP2013516978A JP2013516978A (ja) 2013-05-16
JP2013516978A5 true JP2013516978A5 (https=) 2014-02-27
JP6009357B2 JP6009357B2 (ja) 2016-10-19

Family

ID=43982270

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012548518A Expired - Fee Related JP6009357B2 (ja) 2010-01-12 2011-01-12 アデノウイルスベクターの生産方法およびそれによって生成されるウイルス調製物

Country Status (6)

Country Link
US (2) US20130052165A1 (https=)
EP (1) EP2523681A1 (https=)
JP (1) JP6009357B2 (https=)
IL (1) IL220922B (https=)
SG (2) SG182490A1 (https=)
WO (1) WO2011086509A1 (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003222427B8 (en) 2000-11-17 2010-04-29 Vascular Biogenics Ltd. Promoters exhibiting endothelial cell specificity and methods of using same
US8071740B2 (en) 2000-11-17 2011-12-06 Vascular Biogenics Ltd. Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis
CN100506284C (zh) 2001-10-19 2009-07-01 脉管生物生长有限公司 多核苷酸构建体、药物组合物以及靶向的下调血管生成和抗癌的治疗方法
EP2051988A4 (en) 2006-07-31 2010-06-02 Vascular Biogenics Ltd POLYPEPTIDES AND THESE CODING POLYNUCLEOTIDES AND THEIR USE IN THE TREATMENT OF MEDICAL DISEASES RELATED TO ISCHEMIA
NZ601324A (en) 2010-01-05 2014-10-31 Vascular Biogenics Ltd Methods for use of a specific anti-angiogenic adenoviral agent
AU2011204407B2 (en) 2010-01-05 2015-05-07 Vascular Biogenics Ltd. Compositions and methods for treating glioblastoma GBM
PL2908865T3 (pl) * 2012-10-17 2019-08-30 Vascular Biogenics Ltd. Adenowirus wykazujący ekspresję chimery Fas i jego zastosowanie w sposobach leczenia raka
CN103012591B (zh) * 2012-12-12 2014-05-14 武汉吉爱生物技术有限公司 抗Benzonase单克隆抗体、其制备方法和应用
EP2951307B1 (en) 2013-02-04 2019-12-25 Vascular Biogenics Ltd. Methods of inducing responsiveness to anti-angiogenic agent
EP2970920B1 (en) * 2013-03-15 2018-04-25 The Children's Hospital of Philadelphia Scalable manufacturing process to produce recombinant lentiviral vectors in serum-free suspension cell culture system
CN107603956A (zh) * 2017-08-24 2018-01-19 乾元浩生物股份有限公司 一种禽腺病毒纸片载体潮汐式悬浮培养方法
CN107630004B (zh) * 2017-09-01 2021-01-15 康希诺生物股份公司 降低可复制性腺病毒产生的细胞株及构建方法和应用

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL154600B (nl) 1971-02-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen.
NL154598B (nl) 1970-11-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
NL154599B (nl) 1970-12-28 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen, alsmede testverpakking.
US3901654A (en) 1971-06-21 1975-08-26 Biological Developments Receptor assays of biologically active compounds employing biologically specific receptors
US3853987A (en) 1971-09-01 1974-12-10 W Dreyer Immunological reagent and radioimmuno assay
US3867517A (en) 1971-12-21 1975-02-18 Abbott Lab Direct radioimmunoassay for antigens and their antibodies
NL171930C (nl) 1972-05-11 1983-06-01 Akzo Nv Werkwijze voor het aantonen en bepalen van haptenen, alsmede testverpakkingen.
US3850578A (en) 1973-03-12 1974-11-26 H Mcconnell Process for assaying for biologically active molecules
US3935074A (en) 1973-12-17 1976-01-27 Syva Company Antibody steric hindrance immunoassay with two antibodies
US3996345A (en) 1974-08-12 1976-12-07 Syva Company Fluorescence quenching with immunological pairs in immunoassays
US4034074A (en) 1974-09-19 1977-07-05 The Board Of Trustees Of Leland Stanford Junior University Universal reagent 2-site immunoradiometric assay using labelled anti (IgG)
US3984533A (en) 1975-11-13 1976-10-05 General Electric Company Electrophoretic method of detecting antigen-antibody reaction
US4098876A (en) 1976-10-26 1978-07-04 Corning Glass Works Reverse sandwich immunoassay
US4879219A (en) 1980-09-19 1989-11-07 General Hospital Corporation Immunoassay utilizing monoclonal high affinity IgM antibodies
US5011771A (en) 1984-04-12 1991-04-30 The General Hospital Corporation Multiepitopic immunometric assay
US4666828A (en) 1984-08-15 1987-05-19 The General Hospital Corporation Test for Huntington's disease
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4801531A (en) 1985-04-17 1989-01-31 Biotechnology Research Partners, Ltd. Apo AI/CIII genomic polymorphisms predictive of atherosclerosis
US5272057A (en) 1988-10-14 1993-12-21 Georgetown University Method of detecting a predisposition to cancer by the use of restriction fragment length polymorphism of the gene for human poly (ADP-ribose) polymerase
US5192659A (en) 1989-08-25 1993-03-09 Genetype Ag Intron sequence analysis method for detection of adjacent and remote locus alleles as haplotypes
US5281521A (en) 1992-07-20 1994-01-25 The Trustees Of The University Of Pennsylvania Modified avidin-biotin technique
US5747340A (en) 1994-06-03 1998-05-05 Syntex (U.S.A.) Inc. Targeted gene expression using preproendothelin-1 promoters
WO1997008298A1 (en) * 1995-08-30 1997-03-06 Genzyme Corporation Chromatographic purification of adenovirus and aav
WO1998022588A2 (en) * 1996-11-20 1998-05-28 Introgen Therapeutics, Inc. An improved method for the production and purification of adenoviral vectors
NZ512504A (en) * 1998-12-31 2004-01-30 Aventis Pharma Sa Method for separating viral particles
US6168941B1 (en) * 2000-04-07 2001-01-02 Genvec, Inc. Method of producing adenoviral vector stocks
US20070286845A1 (en) * 2000-11-17 2007-12-13 Vascular Biogenics Ltd. Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis
AU2002348151A1 (en) * 2001-11-05 2003-05-19 Genvec, Inc. Viral vector production methods and compositions
US7459154B2 (en) * 2002-12-26 2008-12-02 Cell Genesys, Inc. Methods and reagents for the enhancement of virus transduction in the bladder epithelium
US20090232808A1 (en) * 2005-01-28 2009-09-17 Apollo Life Sciences Limited Molecules and chimeric molecules thereof
EP2051988A4 (en) * 2006-07-31 2010-06-02 Vascular Biogenics Ltd POLYPEPTIDES AND THESE CODING POLYNUCLEOTIDES AND THEIR USE IN THE TREATMENT OF MEDICAL DISEASES RELATED TO ISCHEMIA

Similar Documents

Publication Publication Date Title
JP2013516978A5 (https=)
JP5465331B2 (ja) 高細胞密度の培養物からのアデノウイルスの精製方法
JP5393896B2 (ja) アデノウイルス粒子の精製方法
ES2329607T3 (es) Metodos de purificacion de virus.
ES2317517T3 (es) Purificacion de virus usando ultrafiltracion.
JP5855564B2 (ja) オルソポックスウイルスの製造および精製方法
CN104694573B (zh) 利用CRISPR/Cas9抑制HIV‑1感染原代淋巴细胞的方法
Han et al. Engineering the PRRS virus genome: updates and perspectives
EP3020808B1 (en) Method for manufacturing adeno-associated virus
JP6009357B2 (ja) アデノウイルスベクターの生産方法およびそれによって生成されるウイルス調製物
KR20150122674A (ko) 아데노바이러스의 생산 방법
JP2000514290A (ja) 組換えアデノウイルスの製造方法
CN110741081B (zh) 肿瘤选择性tata盒和caat盒突变体
KR20140139509A (ko) 터미널 말단이 변경된 재조합 아데노바이러스의 배치
CN104846013A (zh) 一种复制缺陷型人55型腺病毒载体及其制备方法和应用
WO2015128500A1 (en) A process for the preparation of group b adenoviruses
ZA200500047B (en) Tumor-lysing virus growing selectively in tumor cells
CN102284058A (zh) 复制缺陷型抗ev71和ca16病毒双价疫苗的制备方法
CN116286685A (zh) 一种基于CRISPR-Cas9技术的表达H9N2禽流感病毒XZ491毒株HA蛋白的重组血清4型禽腺病毒及其制备方法
US20080267992A1 (en) Sars Virus Vaccine with Adenovirus Carrier and Preparation Method Thereof, and Use of Sars Virus S Gene for Preparation of Vaccine
CN101768576B (zh) Hsv1-tk基因重组溶瘤腺病毒及其制备方法和应用
US20050079158A1 (en) Construct of anti-cancer recombinant adenovirus, method for preparing the same and use thereof
CN107164337B (zh) 含ccl5和sstr2基因的重组痘病毒及其制备方法
CN103881985B (zh) 狂犬病病毒era减毒疫苗突变株及其制备方法和狂犬病活疫苗
CN103305534A (zh) 一种水貂肠炎病毒反向遗传学操作系统及其应用